Medicare Enrolled
Dr. Saleemah Fahmi, MD
Endocrinology · Dallas, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fahmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fahmi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fahmi
Dr. Saleemah Fahmi is an endocrinology specialist in Dallas, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Fahmi performed 1,827 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fahmi received a total of $1,049,759 from 60 pharmaceutical and/or device companies across 2697 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fahmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 24% volume in TX
$1,049,759 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,827
Medicare services
Top 24% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
904 | $90 | $193 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
166 | $98 | $252 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
159 | $119 | $349 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
156 | $10 | $50 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
155 | $102 | $300 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
151 | $25 | $84 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $121 | $261 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
43 | $4 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $123 | $298 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
12 | $45 | $95 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$1,049,759
Total received (2018-2024)
Avg $149,966/year across 7 years
Top 2% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
2,697
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$245,948
2023
$115,612
2022
$101,270
2021
$111,198
2020
$91,241
2019
$201,897
2018
$182,594
Payments by company (2024)
Corcept Therapeutics
$106,054
Amgen Inc.
$61,830
Lilly USA, LLC
$57,173
Abbott Laboratories
$12,893
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,606
ABBVIE INC.
$2,414
Medtronic, Inc.
$852
Xeris Pharmaceuticals, Inc.
$263
SANOFI-AVENTIS U.S. LLC
$146
Dexcom, Inc.
$138
Mannkind Corporation
$100
Bayer Healthcare Pharmaceuticals Inc.
$97
Novo Nordisk Inc
$95
Insulet Corporation
$82
RECORDATI_RARE_DISEASES_INC.
$32
Neurocrine Biosciences, Inc.
$26
Astellas Pharma US Inc
$24
CeQur Corporation
$22
IBSA Pharma Inc.
$21
Amneal Pharmaceuticals LLC
$19
Currax Pharmaceuticals LLC
$17
Sequel Med Tech, LLC
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
BETA BIONICS, INC.
$13
Top 3 companies account for 91.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$514,652
Corcept Therapeutics
$186,769
Shire North American Group Inc
$74,066
SANOFI-AVENTIS U.S. LLC
$72,605
Amgen Inc.
$62,415
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$28,325
AbbVie, Inc.
$17,993
Horizon Therapeutics plc
$16,622
Abbott Laboratories
$14,829
Boehringer Ingelheim Pharmaceuticals, Inc.
$14,417
Janssen Pharmaceuticals, Inc
$9,893
Novo Nordisk Inc
$7,274
AbbVie Inc.
$6,184
ABBVIE INC.
$5,806
Mannkind Corporation
$5,241
Medtronic MiniMed, Inc.
$3,582
AstraZeneca Pharmaceuticals LP
$1,899
Medtronic, Inc.
$1,257
Xeris Pharmaceuticals, Inc.
$1,223
MannKind Corporation
$769
Dexcom, Inc.
$720
Merck Sharp & Dohme Corporation
$369
Bayer Healthcare Pharmaceuticals Inc.
$288
Insulet Corporation
$281
Zealand Pharma US, Inc.
$271
IBSA Pharma Inc.
$203
Bayer HealthCare Pharmaceuticals Inc.
$164
Amryt Pharma Holdings Ltd
$152
Amneal Pharmaceuticals LLC
$142
Novartis Pharmaceuticals Corporation
$111
PFIZER INC.
$94
Amarin Pharma Inc.
$93
Esperion Therapeutics, Inc.
$84
RECORDATI_RARE_DISEASES_INC.
$75
Intuity Medical Inc
$71
DEXCOM, INC.
$71
Currax Pharmaceuticals LLC
$70
Tandem Diabetes Care, Inc.
$69
Janssen Scientific Affairs, LLC
$66
LifeScan, Inc.
$64
Merck Sharp & Dohme LLC
$51
Ultragenyx Pharmaceutical Inc.
$43
Radius Health, Inc.
$39
Valeritas, Inc.
$35
CeQur Corporation
$35
Gilead Sciences, Inc.
$30
Regeneron Healthcare Solutions, Inc.
$27
Neurocrine Biosciences, Inc.
$26
Astellas Pharma US Inc
$24
Ascendis Pharma Inc
$20
Amphastar Pharmaceuticals, Inc.
$20
Nalpropion Pharmaceuticals, Inc.
$18
Sequel Med Tech, LLC
$17
Becton, Dickinson and Company
$16
Kyowa Kirin, Inc.
$15
ARBOR PHARMACEUTICALS, INC.
$14
BETA BIONICS, INC.
$13
Aytu BioScience, Inc
$13
VistaPharm, Inc.
$13
Allergan Inc.
$12
Top 3 companies account for 73.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano · CONTRAVE · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DISEASE STATE · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Enlite Sensor · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMALOG · HUMULIN · HUMULIN R 500 · HUMULIN U · Horizant · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LYRICA · LYUMJEV · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · Natesto · ONZETRA XSAIL · OT Verio Flex Starter Kit · Omnipod · OneTouch · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
77
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
METHODIST CHARLTON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fahmi is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fahmi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fahmi performed 904 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fahmi receive payments from pharmaceutical companies?
Yes. Dr. Fahmi received a total of $1,049,759 from 60 companies across 2,697 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fahmi's costs compare to other endocrinologists in Dallas?
Dr. Fahmi's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fahmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Dallas
Browse endocrinologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
By company
Shire North American Group Inc Payments to Doctors
See all physicians who received payments from Shire North American Group Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology